Drug Profile
Escherichia coli immune globulin - ImmuCell
Latest Information Update: 01 Oct 1998
Price :
$50
*
At a glance
- Originator ImmuCell
- Class Immunoglobulins
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Escherichia coli infections